【招商电子】汇聚科技（1729.HK）配售募资注入强劲动能，战略投资及海外扩张加速

Core Viewpoint - The company successfully completed a placement of 108 million shares at a price of HKD 15.22 per share, raising approximately HKD 1,634.5 million, which will be allocated for strategic investments, global business expansion, and operational funding [1]. Group 1: Fund Utilization - Approximately 50% of the net proceeds will support strategic investments and acquisitions [1]. - About 30% will be used for global business development and overseas expansion [1]. - The remaining 20% will be allocated for working capital and general corporate purposes to support business operations and growth [1]. Group 2: Growth Strategy - The company focuses on both organic and external growth to strengthen its core business through vertical and horizontal integration [2]. - Vertical integration aims to enhance control over key supply chain segments and expand manufacturing capabilities to other regions [2]. - Horizontal integration will focus on businesses aligned with core competencies, including cable operations and high-growth sectors like medical technology [2]. Group 3: Future Outlook - The company is positioned as a core supplier for Google MPO, with growth driven by AI computing demand, automotive sector integration, and medical technology advancements [2]. - The automotive business is expected to benefit from successful integration with Leoni, leading to improved profit levels due to automation and new customer acquisition [2]. - The medical segment is anticipated to grow in the long term due to increasing demand for medical device connectivity driven by aging populations and heightened health awareness [2]. Group 4: Investment Rating - The company is a key component of the Luxshare system, with strong positioning in MPO optical communication and AI server markets, indicating potential for high-quality growth [3]. - The automotive segment is expected to rapidly ascend to a leading global automotive cable supplier due to the successful acquisition of Leoni [3]. - The medical device business is well-positioned for long-term growth, supported by strategic investments in cutting-edge technology [3].